FDA approves first generic of Mylan's EpiPen
U.S. health regulators on Thursday approved Teva Pharmaceutical Industries Ltd's generic of Mylan NV's EpiPen, making it the first copycat version of the life-saving allergy treatment.
from Reuters: Health News https://reut.rs/2MRRMHy
http://bit.ly/2zwRqiM